Literature DB >> 8071954

A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected.

T Coelho1, A Sousa, E Lourenço, J Ramalheira.   

Abstract

We reviewed 1233 cases of familial amyloidotic polyneuropathy (FAP) from 489 Portuguese families registered at the Centro de Estudos de Paramiloidose, Porto, Portugal. It was found that in 159 cases, neither parent had shown symptoms of this hereditary dominant form of peripheral neuropathy. These cases appear to form a distinct group, with a later age at onset (mean 45.1 years, SD 12.0) than the group of patients with one affected parent (mean 31.2 years, SD 6.9) and a geographical origin not quite in the areas where the disease is most prevalent. Though this group is not significantly different from the general group of patients in clinical presentation at onset and severity of the disease, the average interval between onset and diagnosis (mean 4.5 years, SD 3.2) reflects the difficulties in diagnosing these patients in the absence of a positive family history. From the analysis of pedigrees and in spite of a large number of isolated cases, the occurrence of new mutations could not be proven, and it seems more likely that, in some families, the FAP gene may result in a milder expression or even remain "silent" for several generations. Further investigation of this discrepancy may prove to be important in elucidating the mechanisms involved in the pathogenetic process.

Entities:  

Mesh:

Year:  1994        PMID: 8071954      PMCID: PMC1049801          DOI: 10.1136/jmg.31.4.293

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  15 in total

1.  Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden.

Authors:  R Andersson
Journal:  Acta Med Scand Suppl       Date:  1976

2.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.

Authors:  C ANDRADE
Journal:  Brain       Date:  1952-09       Impact factor: 13.501

3.  Structurally abnormal transthyretin causing familial amyloidotic polyneuropathy in Sweden.

Authors:  M Nakazato; L Steen; G Holmgren; T Kurihara; S Matsukura; K Kangawa; H Matsuo
Journal:  Clin Chim Acta       Date:  1987-08-31       Impact factor: 3.786

4.  Hereditary amyloidosis with polyneuropathy.

Authors:  R Andersson
Journal:  Acta Med Scand       Date:  1970 Jul-Aug

5.  The genetic aspect of the familial amyloidotic polyneuropathy. Portuguese type of paramyloidosis.

Authors:  C Andrade; M Canijo; D Klein; A Kaelin
Journal:  Humangenetik       Date:  1969

6.  Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis.

Authors:  G Holmgren; E Holmberg; A Lindström; E Lindström; I Nordenson; O Sandgren; L Steen; B Svensson; E Lundgren; A von Gabain
Journal:  Clin Genet       Date:  1988-03       Impact factor: 4.438

7.  Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence.

Authors:  A Sousa; R Andersson; U Drugge; G Holmgren; O Sandgren
Journal:  Hum Hered       Date:  1993 Sep-Oct       Impact factor: 0.444

8.  Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy.

Authors:  M J Saraiva; P P Costa; D S Goodman
Journal:  Neurology       Date:  1986-11       Impact factor: 9.910

9.  Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis.

Authors:  U Drugge; R Andersson; F Chizari; M Danielsson; G Holmgren; O Sandgren; A Sousa
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

10.  Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type).

Authors:  S Tawara; M Nakazato; K Kangawa; H Matsuo; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

View more
  18 in total

1.  [Hereditary cardiac amyloidosis with transthyretin mutations. A cause of sudden death ].

Authors:  C Edler; W Saeger; U Orth; C Braun; B Wulff; J Sperhake
Journal:  Herz       Date:  2012-06       Impact factor: 1.443

2.  Transthyretin-related familial amyloid polyneuropathy: evaluation of CSF enhancement on serial T1-weighted and fluid-attenuated inversion recovery images following intravenous contrast administration.

Authors:  Toshinori Hirai; Yukio Ando; Masayuki Yamura; Mika Kitajima; Yoshiko Hayashida; Yukunori Korogi; Taro Yamashita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.

Authors:  Haruki Koike; Yuichi Kawagashira; Masahiro Iijima; Masahiko Yamamoto; Naoki Hattori; Fumiaki Tanaka; Masaaki Hirayama; Yukio Ando; Shu-ichi Ikeda; Gen Sobue
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

4.  A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.

Authors:  Miguel Alves-Ferreira; Teresa Coelho; Diana Santos; Jorge Sequeiros; Isabel Alonso; Alda Sousa; Carolina Lemos
Journal:  Mol Neurobiol       Date:  2017-05-19       Impact factor: 5.590

5.  A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.

Authors:  K Yamamoto; S Ikeda; N Hanyu; S Takeda; N Yanagisawa
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

Review 6.  The genetics of cardiac amyloidosis.

Authors:  Scott Arno; Jennifer Cowger
Journal:  Heart Fail Rev       Date:  2021-09-13       Impact factor: 4.654

7.  Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy.

Authors:  Dong Hwee Kim; Steven R Zeldenrust; Phillip A Low; Peter J Dyck
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

8.  Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.

Authors:  Thomas Rudolph; Martin Wilhelm Kurz; Elisabeth Farbu
Journal:  Clin Med Res       Date:  2008-07-07

9.  Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study.

Authors:  Alice Lopes; Alexandra Sousa; Isabel Fonseca; Margarida Branco; Carla Rodrigues; Teresa Coelho; Jorge Sequeiros; Paula Freitas
Journal:  J Community Genet       Date:  2017-10-19

10.  Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial Presentation.

Authors:  Giulietta Riboldi; Roberto Del Bo; Michela Ranieri; Francesca Magri; Monica Sciacco; Maurizio Moggio; Nereo Bresolin; Stefania Corti; Giacomo P Comi
Journal:  Case Rep Neurol       Date:  2011-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.